Khullani Abdullahi
Public Communications Contact chez CARDIO DIAGNOSTICS HOLDINGS, INC.
Fortune : 10 508 $ au 30/04/2024
Profil
Khullani M.
Abdullahi is currently working as the Vice President-Revenue & Strategy at Cardio Diagnostics Holdings, Inc. They previously worked at Cardio Diagnostics, Inc. in the same role.
Ms. Abdullahi completed their undergraduate degree at Carleton College and their graduate degree at The University of Minnesota Law School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/04/2024 | 14 554 ( 0,07% ) | 10 508 $ | 30/04/2024 |
Postes actifs de Khullani Abdullahi
| Sociétés | Poste | Début |
|---|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Public Communications Contact | 25/10/2022 |
Anciens postes connus de Khullani Abdullahi
| Sociétés | Poste | Fin |
|---|---|---|
Cardio Diagnostics, Inc.
 Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Corporate Officer/Principal | - |
Formation de Khullani Abdullahi
| Carleton College | Undergraduate Degree |
| The University of Minnesota Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARDIO DIAGNOSTICS HOLDINGS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |